BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 21, 2018
View Archived Issues
GeNeuro monoclonal antibody GNbAC-1 receives U.S. orphan designation for CIDP
Read More
BX-795 as a promising new antiviral agent against HSV-1 infection of the eye
Read More
Vical starts phase II trial of VL-2397 for treatment of invasive aspergillosis
Read More
Allergan exercises third option for DARPin product candidates
Read More
Umeclidinium has clinical effects in phase II study in palmar hyperhidrosis
Read More
FDA accepts Acorda Therapeutics' NDA for Inbrija
Read More
INSERM and collaborators patent antibodies targeting tumor associated macrophages
Read More
Xenon Pharmaceuticals initiates clinical testing of antiepileptic drug candidate XEN-901
Read More
Novel apoptosis regulator Bcl-2 and/or Bcl-xl inhibitors identified at the University of Michigan
Read More
Pivotal phase III PALISADE study of AR-101 meets primary endpoint
Read More
University of Hong Kong presents new platinum complexes
Read More
Sunshine Lake Pharma identifies new farnesoid X receptor agonists
Read More
Max-Planck-Gesellschaft describes novel influenza type b vaccines
Read More
Cullinan Oncology, MAB Discovery announce agreement to develop novel antibody therapeutics
Read More
Mirikizumab improves quality of life of patients with moderate to severe psoriasis
Read More
Imugene reports preclinical in vivo data for arginine modulator
Read More
Cedars-Sinai and Emulate pioneer Patient-on-a-Chip program
Read More
FDA denies PTC Therapeutics' appeal regarding ataluren NDA, but suggests possible path forward
Read More
3D Signatures announces topline results for Telo-HL test for Hodgkin's lymphoma
Read More
Genexine to use PharmaJet devices in clinical studies
Read More
Soleno Therapeutics completes end-of-phase II meeting for diazoxide choline controlled-release
Read More
Celgene licenses technology from Amunix
Read More
Alcyone Lifesciences' hydrocephalus business now new company
Read More
Safety data presented for tivozanib combined with nivolumab in patients with mRCC
Read More
Tetraphase and Everest Medicines sign licensing agreement for eravacycline in China
Read More
DNA origami-designed nanorobot delivers thrombin specifically to tumors
Read More
Tell us what you think about TRDN
Read More